SPY326.52+2.56 0.79%
DIA264.35+1.07 0.41%
IXIC10,745.28+157.46 1.49%
News
SAVA
--
0.00%
--
Cassava Sciences (SAVA) Jumps: Stock Rises 9.2%
Zacks · 07/14 13:44
80 Biggest Movers From Yesterday
Gainers Equillium, Inc. (NASDAQ: EQ) shares surged 730.7% to close at $26.50 on Monday after the company disclosed that Itolizumab significantly reduced mortality in coronavirus patients, according to a clinical trial conducted in India by its partner Biocon.
Benzinga · 07/14 09:11
The Week Ahead In Biotech: J&J Kickstarts Pharma Earnings, Repare Therapeutics IPO
Biotech stocks advanced in the week ended July 10 amid mixed news flow emerging out of the sector.
Benzinga · 07/12 15:25
Cassava Sciences to Give Keynote Presentation on SavaDx at a Scientific Conference
GlobeNewswire · 07/09 21:01
Cassava Sciences To Give Keynote Presentation On SavaDx At Biomarkers for Alzheimer's Disease Summit Jul. 15
AUSTIN, Texas, July 09, 2020 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ:SAVA), a biotechnology company focused on Alzheimer’s disease, today announced that its lead neuroscientist, Lindsay H. Burns, PhD,
Benzinga · 07/09 20:03
Cassava Sciences: Not Giving Up On Alzheimer's Treatment Yet
Seeking Alpha - Article · 06/16 22:38
Cassava Sciences Added to Russell Indexes and Provides Phase 2b Study Update
GlobeNewswire · 06/16 13:15
Cassava Sciences Added To Russell Indexes And Provides Phase 2b Study Update
AUSTIN, Texas, June 16, 2020 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ:SAVA), a clinical-stage biotechnology company focused on Alzheimer's disease, today announced that the Company will be added to the
Benzinga · 06/16 12:16
Hedge Funds Cautiously Watching Cassava Sciences, Inc. (SAVA)
Insider Monkey · 06/10 21:33
FSD Pharma Jumps On COVID-19 Trial Progress, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha - Article · 06/05 16:20
AAL, LK, SMAR and SAVA among midday movers
Seeking Alpha - Article · 06/04 16:42
SMAR, CHNG among premarket losers
Seeking Alpha - Article · 06/04 13:17
APPS, SAVA, PGEN and LPI among midday movers
Seeking Alpha - Article · 06/03 16:42
MFGP, CRWD among premarket gainers
Seeking Alpha - Article · 06/03 13:15
Cassava Sciences Announces Presentation at the Jefferies Virtual Healthcare Conference and Provides Updates Regarding Phase 2b Study of PTI-125
GlobeNewswire · 06/03 13:15
Cassava Sciences rallies on hopes for Alzheimer's candiate PTI-125
Seeking Alpha - Article · 06/03 12:51
Cassava Sciences Provides Updates Regarding Phase 2b Study of PTI-125, Announces Presentation at the Jefferies Virtual Healthcare Conference
- High Variability in Levels of Biomarkers in Control Arm of Phase 2b Study May Drive Reassessment of Overall Study Results -   - Effects Of PTI-125 on Cognition, Other Analysis and Data Expected 2nd Half 2020
High Variability in Levels of Biomarkers in Control Arm of Phase 2b Study May Drive Reassessment of Overall Study Results -   - Effects Of PTI-125 on Cognition, Other Analysis and Data Expected 2nd Half 2020 · 06/03 12:22
Cassava Sciences (SAVA): Lets Shed Some Light on That Crash
TipRanks · 05/20 00:57
Cassava Slumped Last Week After Bad Data, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha - Article · 05/19 19:12
Cassava Sciences (SAVA) in Focus: Stock Moves 8.5% Higher
Zacks · 05/19 14:46